Sign in
WENAW Stock Price, Chart, Stats & News
Anew Medical, Inc.
Save
Anew Medical, Inc. (WENAW) does not currently pay a dividend.
681,444
Market cap
–
Current P/E
–
Forward P/E
WENAW chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | 33.91% |
ROA | 6.92% |
ROE | 2.16% |
D/E | 0.14x |
Interest coverage ratio | – |
WENAW valuation
P/E | – |
P/S | – |
P/B | 0.63x |
P/CF | -5.61x |
P/FCF | -12.23x |
P/OCF | -5.61x |
PEG | 0.05x |
EV multiple | -10.77x |
About
Anew Medical, Inc., a biopharmaceutical enterprise, is dedicated to pioneering advanced therapies for neurological and age-related disorders, alongside developing specialized diagnostic tools. The company's diverse portfolio encompasses cutting-edge cell and gene therapies, specifically designed to mitigate the progression of age-related pathologies, including symptoms of dementia, Alzheimer's disease, and various neuromuscular conditions. Anew Medical also develops biologics and biosimilars for the treatment of cancer, and conducts research into melanocortin receptor systems.
Similar securities
Based on sector and market capitalization
Report issue